glp-1 agonists vision loss blindness Recent studies have begun to explore a possible link between receptor (like semaglutide) and a rare but serious cause of sudden known as non-arteritic anterior ischemic Sudden vision loss or blurring

Additionally, we were unable to evaluate the exact reasons for drug prescriptions, medication switches, or adherence

GLP-1 agonists cannot stop this process

[DOI] [PMC free article] [PubMed] [Google Scholar] 11.Whytock KL, Carnero EA, Vega RB, Tillner J, Bock C, Chivukula K, et al

The researchers of that study called for urgent clarification of drug- and patient-related risk factors, an understanding that has become more important as GLP-1 receptor agonist use continues to rise across the United States, especially for weight management

Bocarsly adds that research in her lab found that increasing insulin in the reward center of the brain in mice also increased dopamine, and dopamine dysregulation is present in Parkinsons disease, schizophrenia, and bipolar disorder